CC-486 and Venetoclax for Acute Myeloid Leukemia

Primary Objective

To determine the maximum tolerated or recommended dose of CC-486 in combination with venetoclax

This Study is
No Longer Enrolling

Details
Age

Adult

Type of Study

Treatment

Locations

Lone Tree Medical Center
University of Colorado Hospital

Study ID

Protocol Number: 20-1319

More information available at ClinicalTrials.gov: NCT05287568

Categories

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers